Primary Intestinal Lymphangiectasia in Children: Is Octreotide an Effective and Safe Option in the Treatment?

SARI S., Baris Z., DALGIÇ B.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, vol.51, no.4, pp.454-457, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 4
  • Publication Date: 2010
  • Doi Number: 10.1097/mpg.0b013e3181d1b162
  • Journal Name: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.454-457
  • Keywords: children, intestinal lymphangiectasia, octreotide, ACQUIRED-IMMUNODEFICIENCY-SYNDROME, SLOW-RELEASE OCTREOTIDE, INDUCED PANCREATITIS, SOMATOSTATIN, ABSORPTION, SPHINCTER, THERAPY, PATIENT
  • Eskisehir Osmangazi University Affiliated: No

Abstract

Objective: Octreotide has been suggested as a medical treatment option in refractory cases of primary intestinal lymphangiectasia (IL). There are few data about the long-term effect and safety of octreotide for IL in the literature. In the present article we analyzed pediatric cases of primary IL with long-term octreotide treatment and discussed its safety profile.